Skip to main content
Top
Published in: European Journal of Epidemiology 12/2009

01-12-2009 | COMMENTARY

Thinking big: large-scale collaborative research in observational epidemiology

Author: Alexander Thompson

Published in: European Journal of Epidemiology | Issue 12/2009

Login to get access

Abstract

Efforts to identify risk factors for chronic diseases have tended to involve observational studies characterised by relatively few disease outcomes. In the absence of individual studies of sufficiently large size, synthesis of available evidence from multiple smaller studies can help enhance statistical power and aid appropriate interpretation. While meta-analyses of published findings can help prioritize research hypotheses, they are inherently limited by the scale of the evidence available for review and by vulnerability to potential reporting biases. By contrast, collaborative analyses of individual participant data from a comprehensive set of relevant epidemiological studies can offer several advantages over moderately sized individual studies or meta-analyses of aggregated data. This review describes those advantages with reference to selected examples.
Literature
1.
go back to reference Weinberg AM. Impact of large-scale science on the United States: big science is here to stay, but we have yet to make the hard financial and educational choices it imposes. Science. 1961;134(3473):161–4.CrossRefPubMed Weinberg AM. Impact of large-scale science on the United States: big science is here to stay, but we have yet to make the hard financial and educational choices it imposes. Science. 1961;134(3473):161–4.CrossRefPubMed
2.
go back to reference Galison P. The many faces of big science. In: Galison P, Hevly B, editors. Big science: the growth of large-scale research. Stanford: Stanford University Press; 1992. p. 1–17. Galison P. The many faces of big science. In: Galison P, Hevly B, editors. Big science: the growth of large-scale research. Stanford: Stanford University Press; 1992. p. 1–17.
3.
go back to reference Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, et al. Cohort profile: the Kadoorie study of chronic disease in China (KSCDC). Int J Epidemiol. 2005;34(6):1243–9.CrossRefPubMed Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, et al. Cohort profile: the Kadoorie study of chronic disease in China (KSCDC). Int J Epidemiol. 2005;34(6):1243–9.CrossRefPubMed
4.
go back to reference Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234–44.CrossRefPubMed Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234–44.CrossRefPubMed
5.
go back to reference Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5(1):14.CrossRefPubMed Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5(1):14.CrossRefPubMed
6.
go back to reference Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002;25(1):76–97.CrossRefPubMed Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002;25(1):76–97.CrossRefPubMed
7.
go back to reference Seminara D, Khoury MJ, O’Brien TR, Manolio T, Gwinn ML, Little J, et al. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007;18(1):1–8.CrossRefPubMed Seminara D, Khoury MJ, O’Brien TR, Manolio T, Gwinn ML, Little J, et al. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007;18(1):1–8.CrossRefPubMed
8.
go back to reference Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341–53.PubMed Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341–53.PubMed
9.
go back to reference The Emerging Risk Factors Collaboration. The emerging risk factors collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22(12):839–69.CrossRef The Emerging Risk Factors Collaboration. The emerging risk factors collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22(12):839–69.CrossRef
10.
go back to reference The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–23.CrossRef The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–23.CrossRef
12.
go back to reference The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000.
13.
go back to reference Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22(9):647–64.CrossRefPubMed Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22(9):647–64.CrossRefPubMed
14.
go back to reference Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 2008;299(23):2777–88.CrossRefPubMed Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 2008;299(23):2777–88.CrossRefPubMed
15.
go back to reference Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008;53(1):1–9.CrossRefPubMed Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008;53(1):1–9.CrossRefPubMed
16.
go back to reference Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005;5(12):977–85.CrossRefPubMed Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005;5(12):977–85.CrossRefPubMed
18.
go back to reference Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, et al. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2007;16(11):2237–46.CrossRefPubMed Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, et al. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2007;16(11):2237–46.CrossRefPubMed
19.
go back to reference Canzian F, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, et al. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer. 2009;9:257.CrossRefPubMed Canzian F, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, et al. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer. 2009;9:257.CrossRefPubMed
21.
go back to reference Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.CrossRefPubMed Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.CrossRefPubMed
22.
go back to reference Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264(4):295–314. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264(4):295–314.
23.
go back to reference CRP CHD Genetics Collaboration. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. Eur J Epidemiol. 2008;23(8):531–40.CrossRef CRP CHD Genetics Collaboration. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. Eur J Epidemiol. 2008;23(8):531–40.CrossRef
24.
25.
go back to reference Bingham S, Riboli E. Diet and cancer—the European prospective investigation into cancer and nutrition. Nat Rev Cancer. 2004;4(3):206–15.CrossRefPubMed Bingham S, Riboli E. Diet and cancer—the European prospective investigation into cancer and nutrition. Nat Rev Cancer. 2004;4(3):206–15.CrossRefPubMed
26.
go back to reference The EPIC-Heart Secretariat. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007;22(2):129–41.CrossRef The EPIC-Heart Secretariat. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007;22(2):129–41.CrossRef
Metadata
Title
Thinking big: large-scale collaborative research in observational epidemiology
Author
Alexander Thompson
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 12/2009
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-009-9412-1

Other articles of this Issue 12/2009

European Journal of Epidemiology 12/2009 Go to the issue